ArticleTherapeutic advances in medical oncology2025
Cost-effectiveness of lazertinib as first-line treatment in patients with
Li-Jung Elizabeth Ku et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it